We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

5 hedge funds and large institutions have $494K invested in Sage Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 185 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

77.93% less ownership

Funds ownership: 78.02% → 0.09% (-78%)

97% less funds holding

Funds holding: 191 → 5 (-186)

100% less capital invested

Capital invested by funds: $446M → $494K (-$445M)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 185

Holders
5
Holders Change
-186
Holders Change %
-97.38%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
185
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$150K
2
IA
IFP Advisors
Florida
+$45

Top Sellers

Rank Fund Capital Flow
1
MAP
Madison Avenue Partners
New York
-$55.4M
2
BlackRock
BlackRock
New York
-$41.5M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$29.8M
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$17.8M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$17.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
DekaBank Deutsche Girozentrale
1
DekaBank Deutsche Girozentrale
Germany
$455K – – –
Osaic Holdings
2
Osaic Holdings
Arizona
$35.1K -$1.24K -138 -3%
IA
3
IFP Advisors
Florida
$3.86K +$45 +5 +1%
HNB
4
Huntington National Bank
Ohio
$9 – – –
MAP
5
Madison Avenue Partners
New York
– -$55.4M -6,077,065 Closed
BlackRock
6
BlackRock
New York
– -$41.5M -4,545,458 Closed
Vanguard Group
7
Vanguard Group
Pennsylvania
– -$29.8M -3,265,802 Closed
Hudson Bay Capital Management
8
Hudson Bay Capital Management
Connecticut
– -$17.8M -1,952,245 Closed
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
– -$17.5M -1,917,284 Closed
Balyasny Asset Management
10
Balyasny Asset Management
Illinois
– -$13.8M -1,518,170 Closed
Geode Capital Management
11
Geode Capital Management
Massachusetts
– -$12.4M -1,356,577 Closed
AAM
12
Alpine Associates Management
Florida
– -$11.6M -1,273,348 Closed
State Street
13
State Street
Massachusetts
– -$10.6M -1,166,002 Closed
6CM
14
683 Capital Management
New York
– -$10.5M -1,150,000 Closed
Marshall Wace
15
Marshall Wace
United Kingdom
– -$10.5M -1,147,571 Closed
Renaissance Technologies
16
Renaissance Technologies
New York
– -$10.2M -1,113,400 Closed
Toronto Dominion Bank
17
Toronto Dominion Bank
Ontario, Canada
– -$9.87M -1,082,120 Closed
Qube Research & Technologies (QRT)
18
Qube Research & Technologies (QRT)
United Kingdom
– -$9.87M -1,082,003 Closed
Millennium Management
19
Millennium Management
New York
– -$9.14M -1,002,709 Closed
HM
20
Harvest Management
New York
– -$8.11M -889,200 Closed
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
– -$7.97M -874,166 Closed
AQR Capital Management
22
AQR Capital Management
Connecticut
– -$7.86M -861,366 Closed
RC
23
Rangeley Capital
Connecticut
– -$6.66M -730,000 Closed
ACM
24
ADAR1 Capital Management
Texas
– -$6.58M -721,599 Closed
NM
25
Newtyn Management
New York
– -$6.38M -700,000 Closed
1
2 3 4 5

SAGE Hedge Fund Activity: Q3 2025 in Review

5 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q3 2025, worth a combined $494K — down 100% from $446M a quarter earlier.

Sellers outnumbered buyers: 185 funds closed out of SAGE and 0 opened new positions — a net loss of 185 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was XTX Topco, adding an estimated $150K. The largest seller was Madison Avenue Partners, exiting entirely with an estimated $55.4M sold.

  • 5 institutional investors held Sage Therapeutics (SAGE) as of Q3 2025, down from 191 in Q2 2025.
  • Funds reported $494K of Sage Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Sage Therapeutics positions in Q3 2025 and 185 closed out, a net change of -185 holders.
  • The largest Sage Therapeutics buyer in Q3 2025 was XTX Topco, an estimated $150K added.
  • The largest Sage Therapeutics seller in Q3 2025 was Madison Avenue Partners, an estimated $55.4M sold.

Based on aggregated 13F filings for Q3 2025.